Medicare Enrolled
Dr. Mitchell Finnie, MD
Family Medicine · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Finnie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Finnie? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Finnie
Dr. Mitchell Finnie is a family medicine in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Finnie performed 7,244 Medicare services across 6,173 unique beneficiaries.
Between the years covered by Open Payments, Dr. Finnie received a total of $15,481 from 72 pharmaceutical and/or device companies across 1010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Finnie is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $15,481 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,244
Medicare services
Top 2% in TX for family medicine
6,173
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~362 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 740 | $86 | $330 |
| Lipid panel (cholesterol and triglycerides) | 641 | $13 | $55 |
| Comprehensive metabolic blood panel | 630 | $10 | $43 |
| Thyroid stimulating hormone (TSH) test | 479 | $16 | $69 |
| Complete blood count (CBC) with differential | 476 | $8 | $32 |
| Hemoglobin A1c test (diabetes monitoring) | 450 | $9 | $40 |
| Annual wellness visit, follow-up | 392 | $124 | $357 |
| Ultrasound study of arm and leg arteries | 299 | $49 | $275 |
| Ultrasound of leg arteries or artery grafts | 279 | $155 | $800 |
| Ultrasound of both sides of head and neck blood flow | 272 | $128 | $620 |
| Annual alcohol misuse screening, 5 to 15 minutes | 245 | $18 | $56 |
| Annual depression screening | 235 | $18 | $56 |
| Free thyroxine (T4) test | 233 | $9 | $37 |
| Magnesium level test | 231 | $7 | $27 |
| Thyroid hormone, t3 measurement, free | 222 | $17 | $69 |
| Prostate cancer screening; prostate specific antigen test (psa) | 118 | $19 | $75 |
| Vitamin D level test | 117 | $29 | $111 |
| Office visit, established patient (20-29 min) | 112 | $61 | $222 |
| Ultrasound scan of head and neck soft tissue | 104 | $86 | $356 |
| Limited ultrasound scan behind abdominal cavity | 75 | $46 | $176 |
| Blood draw (venipuncture) | 73 | $8 | $10 |
| Office visit, established patient, complex (40-54 min) | 63 | $118 | $446 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 58 | $100 | $502 |
| Urinalysis, manual | 55 | $3 | $10 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | $113 | $606 |
| Measurement of brain wave activity (eeg), awake and drowsy | 46 | $279 | $1,098 |
| Measurement of brain wave activity (eeg), digital analysis | 46 | $212 | $969 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 44 | $10 | $39 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 40 | $26 | $118 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $16 | $61 |
| PSA test (prostate cancer screening) | 35 | $18 | $75 |
| Assessment of emotional or behavioral problems | 30 | $3 | $16 |
| Vitamin B-12 level test | 29 | $15 | $62 |
| Limited ultrasound scan of abdomen | 27 | $68 | $281 |
| Complete ultrasound scan behind abdominal cavity | 26 | $84 | $347 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 26 | $181 | $865 |
| Evaluation of neuropsychological test, first hour | 23 | $101 | $407 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 21 | $159 | $512 |
| Iron level test | 18 | $6 | $26 |
| Testosterone (hormone) level, total | 18 | $25 | $105 |
| Iron binding capacity test | 17 | $9 | $36 |
| Sex hormone binding globulin (protein) level | 17 | $21 | $89 |
| Testosterone (hormone) level, free | 17 | $25 | $104 |
| Complete ultrasound scan of abdomen | 15 | $90 | $377 |
| Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | 14 | $65 | $270 |
| Electrocardiogram (EKG), 12-lead | 13 | $10 | $52 |
| New patient office visit (30-44 min) | 13 | $60 | $332 |
| New patient office visit (45-59 min) | 12 | $118 | $505 |
| Office visit, established patient (10-19 min) | 12 | $43 | $134 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,481
Total received (2018-2024)
Avg $2,212/year across 7 years
Top 2% in TX for family medicine
72
Companies
1,010
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,481 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,560
2023$2,160
2022$2,490
2021$2,561
2020$2,078
2019$2,228
2018$2,404
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,664
Novo Nordisk Inc
$1,648
Lilly USA, LLC
$1,049
AstraZeneca Pharmaceuticals LP
$910
Amarin Pharma Inc.
$747
Janssen Pharmaceuticals, Inc
$688
Boehringer Ingelheim Pharmaceuticals, Inc.
$576
ABBVIE INC.
$536
GlaxoSmithKline, LLC.
$487
AbbVie Inc.
$453
Allergan Inc.
$448
PFIZER INC.
$425
Merck Sharp & Dohme Corporation
$392
Allergan, Inc.
$344
Esperion Therapeutics, Inc.
$305
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$287
Merck Sharp & Dohme LLC
$275
SANOFI-AVENTIS U.S. LLC
$267
Paratek Pharmaceuticals, Inc.
$266
Biohaven Pharmaceutical Holding Company Ltd.
$211
Avanir Pharmaceuticals, Inc.
$192
Biohaven Pharmaceuticals, Inc.
$168
Zyla Life Sciences
$152
SHIELD THERAPEUTICS INC
$131
Teva Pharmaceuticals USA, Inc.
$123
Abbott Laboratories
$117
Novartis Pharmaceuticals Corporation
$117
Medtronic Vascular, Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$85
Shield Therapeutics Inc
$81
IDORSIA PHARMACEUTICALS US INC
$81
Corcept Therapeutics
$71
Ironwood Pharmaceuticals, Inc
$70
Takeda Pharmaceuticals U.S.A., Inc.
$63
Nevro Corp.
$58
UPSHER-SMITH LABORATORIES LLC
$56
Althera Pharmaceuticals LLC
$56
Currax Pharmaceuticals LLC
$54
Shire North American Group Inc
$53
Sumitomo Pharma America, Inc.
$49
Astellas Pharma US Inc
$47
Genentech USA, Inc.
$37
Boston Scientific Corporation
$37
ARBOR PHARMACEUTICALS, INC.
$34
Relievant Medsystems, Inc.
$32
Bardy Diagnostics, Inc.
$30
LINUS HEALTH, INC.
$29
Endo Pharmaceuticals Inc.
$26
Hikma Pharmaceuticals USA
$25
Neos Therapeutics, LP
$24
IMPEL PHARMACEUTICALS INC.
$21
Corium, LLC
$20
Alkermes, Inc.
$19
Medtronic, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
Upsher-Smith Laboratories LLC
$16
Supernus Pharmaceuticals, Inc.
$16
Phadia US Inc.
$15
Alfasigma USA, Inc.
$15
Amneal Pharmaceuticals LLC
$15
Mission Pharmacal Company
$14
Otsuka America Pharmaceutical, Inc.
$14
IBSA Pharma Inc.
$13
Bayer Healthcare Pharmaceuticals Inc.
$13
RedHill Biopharma Inc.
$13
Sanofi Pasteur Inc.
$12
Orexigen Therapeutics, Inc.
$12
SI-BONE, Inc.
$12
Adhera Therapeutics, Inc.
$12
AbbVie, Inc.
$12
IRONWOOD PHARMACEUTICALS, INC
$12
CeQur Corporation
$9
Top 3 companies account for 34.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADLARITY · AJOVY · AMS 700 · AREXVY · ASMANEX · Adzenys XR-ODT · Aemcolo · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · CONTRAVE · CORE COGNITIVE EVALUATION · Carnation Ambulatory Monitor · CeQur Simplicity · Cotempla XR-ODT · DUZALLO · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · GENERAL PAIN MANAGEMENT · HUMIRA · IN.PACT Admiral · INVOKANA · ImmunoCAP · Intracept · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · Linzess · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Mitigare · NAMZARIC · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Omnia · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PRESTALIA · PREVNAR - 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULANCE · TRULICITY · Tirosint · Tresiba · Trintellix · Trudhesa · UBRELVY · UNITHROID · Uribel · VANTA ADAPTIVESTIM · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Victoza · Vivitrol · Wegovy · XARELTO · XIFAXAN · Xofluza · ZEMBRACE SYMTOUCH · ZEPBOUND · ZORVOLEX · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Equivalent to $214 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
976
Per 100K population
47.9
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Finnie is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Finnie experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Finnie performed 740 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Finnie receive payments from pharmaceutical companies?
Yes. Dr. Finnie received a total of $15,481 from 72 companies across 1,010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Finnie's costs compare to other family medicines in San Antonio?
Dr. Finnie's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Finnie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in San Antonio
Browse family medicines in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology